These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12650071)

  • 1. [Cellular and molecular mechanism of cardiovascular disease resulting from hyperhomocysteinemia].
    Gao L; Tang CS
    Sheng Li Ke Xue Jin Zhan; 2002 Oct; 33(4):335-8. PubMed ID: 12650071
    [No Abstract]   [Full Text] [Related]  

  • 2. [Risk factors for cardiovascular diseases: what is the role for homocysteine?].
    Bendini MG; Lanza GA; Mazza A; Giordano A; Leggio M; Menichini G; De Cristofaro R; Moriconi E; Cozzari L; Farina SM; Giordano G
    G Ital Cardiol (Rome); 2007 Mar; 8(3):148-60. PubMed ID: 17461357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease.
    Austin RC; Lentz SR; Werstuck GH
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S56-64. PubMed ID: 15243582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of folic acid treatment on homocysteine levels and vascular disease in hemodialysis patients.
    Righetti M; Ferrario GM; Milani S; Serbelloni P; La Rosa L; Uccellini M; Sessa A
    Med Sci Monit; 2003 Apr; 9(4):PI19-24. PubMed ID: 12709680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homocysteine: the latest risk factor for heart disease.
    Reeder SJ; Hoffmann RL; Magdic KS; Rodgers JM
    Dimens Crit Care Nurs; 2000; 19(1):22-8. PubMed ID: 10876482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events.
    Vianna AC; Mocelin AJ; Matsuo T; Morais-Filho D; Largura A; Delfino VA; Soares AE; Matni AM
    Hemodial Int; 2007 Apr; 11(2):210-6. PubMed ID: 17403173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine and atherothrombosis.
    Welch GN; Loscalzo J
    N Engl J Med; 1998 Apr; 338(15):1042-50. PubMed ID: 9535670
    [No Abstract]   [Full Text] [Related]  

  • 9. Diabetes mellitus and hyperhomocysteinemia.
    van Guldener C; Stehouwer CD
    Semin Vasc Med; 2002 Feb; 2(1):87-95. PubMed ID: 16222599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine, B vitamins, and cardiovascular disease.
    Quinlivan EP; Gregory JF
    N Engl J Med; 2006 Jul; 355(2):206; author reply 209-11. PubMed ID: 16838446
    [No Abstract]   [Full Text] [Related]  

  • 11. Lowering plasma homocysteine.
    Med Lett Drugs Ther; 2003 Oct; 45(1168):85-6. PubMed ID: 14576622
    [No Abstract]   [Full Text] [Related]  

  • 12. Methylenetetrahydrofolate reductase polymorphism determines the plasma homocysteine-lowering effect of large-dose folic acid supplementation in patients with cardiovascular disease.
    Liu CS; Chiang HC; Chen HW
    Nutrition; 2004; 20(11-12):974-8. PubMed ID: 15561486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Homocysteine and rheumatic disease].
    Tinazzi I; Caramaschi P; Patuzzo G; Bambara LM; Biasi D
    Recenti Prog Med; 2007 Dec; 98(12):646-52. PubMed ID: 18369042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid administration and antibodies against homocysteinylated proteins in subjects with hyperhomocysteinemia.
    Undas A; Stepień E; Glowacki R; Tisończyk J; Tracz W; Jakubowski H
    Thromb Haemost; 2006 Sep; 96(3):342-7. PubMed ID: 16953277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamins and minerals 4: overview of folate and the B vitamins.
    Thompson J
    Community Pract; 2006 Jun; 79(6):197-8. PubMed ID: 16780289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine and essential hypertension.
    Rodrigo R; Passalacqua W; Araya J; Orellana M; Rivera G
    J Clin Pharmacol; 2003 Dec; 43(12):1299-306. PubMed ID: 14615465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine and arteriosclerosis: subclinical and clinical disease associations.
    Bostom AG; Selhub J
    Circulation; 1999 May; 99(18):2361-3. PubMed ID: 10318653
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hyperhomocysteinemia as a risk factor for cardiovascular diseases].
    Kovaćević G; Andrejević-Kovaćević S; Kostić G; Novak A
    Srp Arh Celok Lek; 2000; 128(11-12):403-8. PubMed ID: 11337922
    [No Abstract]   [Full Text] [Related]  

  • 19. Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology, and the need for randomized trials.
    Splaver A; Lamas GA; Hennekens CH
    Am Heart J; 2004 Jul; 148(1):34-40. PubMed ID: 15215789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperhomocyst(e)inemia as a risk factor after renal transplantation.
    Ducloux D; Motte G; Massy ZA
    Ann Transplant; 2001; 6(4):40-2. PubMed ID: 12035457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.